LIST OF TABLES
TABLE 01. CONVENTIONAL DIAGNOSTICS VERSUS DIAGNOSTIC BIOMARKER TECHNIQUES
TABLE 02. CASE STUDY
TABLE 03. APPLICATIONS AND BENEFITS OF POINT OF CARE TESTING
TABLE 04. CARDIAC BIOMARKERS FOR CVD IN TNT
TABLE 05. CHARACTERISTICS OF CARDIAC BIOMARKER
TABLE 06. GLOBAL CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 07. CARDIAC BIOMARKER TESTING MARKET FOR CREATINE KINASE, BY REGION, 2018–2026 ($MILLION)
TABLE 08. CARDIAC BIOMARKER TESTING MARKET FOR ARTHROSPIRA MAXIMA, BY REGION, 2018–2026 ($MILLION)
TABLE 09. CARDIAC BIOMARKER TESTING MARKET FOR MYOGLOBIN, BY REGION, 2018–2026 ($MILLION)
TABLE 10. CARDIAC BIOMARKER TESTING MARKET FOR NATRIURETIC PEPTIDES (BNP AND NT-PROBNP), BY REGION, 2018–2026 ($MILLION)
TABLE 11. CARDIAC BIOMARKER TESTING MARKET FOR ISCHEMIA MODIFIED ALBUMIN, BY REGION, 2018–2026 ($MILLION)
TABLE 12. CARDIAC BIOMARKER TESTING MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 14. CARDIAC BIOMARKERS USED FOR MONITORING PATIENTS WITH MYOCARDIAL INFRACTIONS
TABLE 15. CARDIAC BIOMARKER TESTING MARKET FOR MYOCARDIAL INFARCTION, BY REGION, 2018–2026, ($MILLION)
TABLE 16. CARDIAC BIOMARKER TESTING MARKET FOR CONGESTIVE HEART FAILURE, BY REGION, 2018–2026, ($MILLION)
TABLE 17. CARDIAC BIOMARKER TESTING MARKET FOR ACUTE CORONARY SYNDROME, BY REGION, 2018–2026, ($MILLION)
TABLE 18. CARDIAC BIOMARKER TESTING MARKET FOR ATHEROSCLEROSIS, BY REGION, 2018–2026, ($MILLION)
TABLE 19. CARDIAC BIOMARKER TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2026, ($MILLION)
TABLE 20. GLOBAL CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 21. CARDIAC BIOMARKER TESTING MARKET FOR POINT OF CARE TESTING, BY REGION, 2018–2026, ($MILLION)
TABLE 22. CARDIAC BIOMARKER TESTING MARKET FOR LABORATORY TESTING, BY REGION, 2018–2026, ($MILLION)
TABLE 23. CARDIAC BIOMARKER TESTING MARKET, BY REGION, 2018–2026, ($MILLION)
TABLE 24. NORTH AMERICA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 25. NORTH AMERICA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 26. NORTH AMERICA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 27. NORTH AMERICA CARDIAC BIOMARKER TESTING MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 28. U.S. CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 29. U.S. CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 30. U.S. CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 31. CANADA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 32. CANADA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 33. CANADA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 34. MEXICO CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 35. MEXICO CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 36. MEXICO CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 37. EUROPE CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 38. EUROPE CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 39. EUROPE CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 40. EUROPE CARDIAC BIOMARKER TESTING MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 41. UK CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 42. UK CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 43. UK CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 44. FRANCE CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 45. FRANCE CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 46. FRANCE CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 47. GERMANY CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 48. GERMANY CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 49. GERMANY CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 50. REST OF EUROPE CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 51. REST OF EUROPE CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 52. REST OF EUROPE CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 53. ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 54. ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 55. ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 56. ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 57. CHINA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 58. CHINA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 59. CHINA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 60. INDIA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 61. INDIA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 62. INDIA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 63. AUSTRALIA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 64. AUSTRALIA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 65. AUSTRALIA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 66. JAPAN CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 67. JAPAN CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 68. JAPAN CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 72. LAMEA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 73. LAMEA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 74. LAMEA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 75. LAMEA CARDIAC BIOMARKER TESTING MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 76. LATIN AMERICA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 77. LATIN AMERICA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 78. LATIN AMERICA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 79. MIDDLE EAST CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 80. MIDDLE EAST CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 81. MIDDLE EAST CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 82. AFRICA CARDIAC BIOMARKER TESTING MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 83. AFRICA CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION, 2018–2026, ($MILLION)
TABLE 84. AFRICA CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING, 2018–2026, ($MILLION)
TABLE 85. ABBOTT: COMPANY SNAPSHOT
TABLE 86. ABBOTT: OPERATING SEGMENTS
TABLE 87. ABBOTT: PRODUCT PORTFOLIO
TABLE 88. BD: COMPANY SNAPSHOT
TABLE 89. BD: OPERATING SEGMENTS
TABLE 90. BD: PRODUCT PORTFOLIO
TABLE 91. BIOMÉRIEUX, INC.: COMPANY SNAPSHOT
TABLE 92. BIOMÉRIEUX, INC.: OPERATING SEGMENTS
TABLE 93. BIO-RAD: COMPANY SNAPSHOT
TABLE 94. BIO-RAD: OPERATING SEGMENTS
TABLE 95. DANAHER: COMPANY SNAPSHOT
TABLE 96. DANAHER: OPERATING SEGMENTS
TABLE 97. ROCHE: COMPANY SNAPSHOT
TABLE 98. ROCHE: OPERATING SEGMENTS
TABLE 99. SEIMENS: COMPANY SNAPSHOT
TABLE 100. SEIMENS: PRODUCT SEGMENTS
TABLE 101. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 102. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 103. PERKINELMER: COMPANY SNAPSHOT
TABLE 104. PERKINELMER: OPERATING SEGMENTS
TABLE 105. TOSOH: COMPANY SNAPSHOT
TABLE 106. TOSOH: OPERATING SEGMENTS LIST OF FIGURES
FIGURE 01. TOP IMPACTING FACTORS, 2018-2026
FIGURE 02. TOP INVESTMENT POCKETS, 2018
FIGURE 03. PARENT MARKET
FIGURE 04. VALUE CHAIN ANALYSIS OF GLOBAL CARDIAC BIOMARKERS
FIGURE 05. PRICING ANALYSIS, BY REGION, 2018 & 2025
FIGURE 06. PATENT ANALYSIS, BY REGION
FIGURE 07. PATENT ANALYSIS, BY APPLICANT
FIGURE 08. MARKET SHARE ANALYSIS, 2018
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR CREATINE KINASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR ARTHROSPIRA MAXIMA, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR MYOGLOBIN, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR NATRIURETIC PEPTIDES (BNP AND NT-PROBNP), BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR ISCHEMIA MODIFIED ALBUMIN, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR NUTRACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR CONGESTIVE HEART FAILURE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR ACUTE CORONARY SYNDROME, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR ATHEROSCLEROSIS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR POINT OF CARE TESTING, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CARDIAC BIOMARKER TESTING MARKET FOR LABORATORY TESTING, BY COUNTRY, 2018 & 2026 (%)
FIGURE 22. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 25. BD: NET SALES, 2015–2017 ($MILLION)
FIGURE 26. BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. BD: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 28. BIOMÉRIEUX, INC.: REVENUE, 2015–2017 ($MILLION)
FIGURE 29. BIOMÉRIEUX, INC.: REVENUE SHARE BY APPLICATION, 2017 (%)
FIGURE 30. BIOMÉRIEUX, INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. BIO-RAD: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. BIO-RAD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 34. DANAHER: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. DANAHER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. DANAHER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. ROCHE: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. ROCHE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 40. SEIMENS: NET SALES, 2016–2018 ($MILLION)
FIGURE 41. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)
FIGURE 42. SEIMENS: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 43. THERMO FISHER SCIENTIFIC: REVENUE, 2016–2018 ($MILLION)
FIGURE 44. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 46. PERKINELMER: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. PERKINELMER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. PERKINELMER: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 49. TOSOH: NET SALES, 2016–2018 ($MILLION)
FIGURE 50. TOSOH: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 51. TOSOH: REVENUE SHARE BY REGION, 2018 (%